Chew Tee-Ming co-founded Mito Health in June 2023 with Kenneth Lou, Joel Kek and Ryan Ware to offer more comprehensive and individualised health screenings (Photo: Darren Gabriel Leow)
Cover Chew Tee-Ming co-founded Mito Health in June 2023 with Kenneth Lou, Joel Kek and Ryan Ware to offer more comprehensive and individualised health screenings (Photo: Darren Gabriel Leow)
Chew Tee-Ming co-founded Mito Health in June 2023 with Kenneth Lou, Joel Kek and Ryan Ware to offer more comprehensive and individualised health screenings (Photo: Darren Gabriel Leow)

Chew Tee-Ming of Mito Health discusses how his startup is using AI to reduce the cost and time taken to generate health screening results and personalised health plans for clients

Healthcare today focuses on sick care, but as preventive treatments and technologies improve, a shift towards extending health and lifespans is expected. Not everyone will aspire to be like tech entrepreneur and “Don’t Die” proponent Bryan Johnson, but more will seek ways to live better for longer. For these people, Chew Tee-Ming’s Mito Health wants to help. 

Read more: Finding the Blueprint for longevity: Inside Bryan Johnson’s mission to cheat death

The startup—which Chew founded in June 2023 with CEO Kenneth Lou, chief technology officer Joel Kek and chief medical officer Ryan Ware—provides comprehensive health screenings that measure more than 100 biomarkers. This includes ApoB (Apolipoprotein B), which can tell you your risk for cardiovascular disease but is not typically tested for in basic medical checks. The results are then put through an artificial intelligence (AI) to generate a personalised health plan for the individual that includes exercise, nutrition, supplements and sleep recommendations.

Ware currently runs through the first draft of the plan and makes the necessary edits. The goal is to automate this tedious process further, according to Chew, to cut down the cost of the screening and the time needed to create the plan.

Tatler Asia
The co-founders of Mito Health: Chief medical officer Dr Ryan Ware, CEO Kenneth Lou, CTO Joel Kek and CPO Chew Tee-Ming (Photo: Mito Health)
Above Mito Health co-founders: chief medical officer Dr Ryan Ware, chief executive officer Kenneth Lou, chief technology officer Joel Kek and chief product officer Chew Tee-Ming (Photo: Mito Health)
The co-founders of Mito Health: Chief medical officer Dr Ryan Ware, CEO Kenneth Lou, CTO Joel Kek and CPO Chew Tee-Ming (Photo: Mito Health)

Since December 2023, Chew says the company has nearly doubled its customer base every month, with a growing waitlist. Given Singapore’s strict regulations around marketing healthcare services, Mito Health relies heavily on word-of-mouth and referrals to grow its client base, says Chew.    

Chew’s interest in personal health grew after he exited his previous company, the personal finance firm Seedly which he also co-founded with Lou. “After exiting, I got a nutrition coach to advise me on eating better and exercises to do,” he says. “I also met with Monk’s Hill Ventures’ Peng T Ong, who shared a few books with me including David Sinclair’s Lifespan: Why We Age―and Why We Don't Have To.” Around that time, Johnson also started making global headlines for his extreme, US$2 million-a-year methods he hopes can keep death at bay. “We thought there’s an opportunity here,” says Chew.

His and Lou’s initial idea for Mito Health was to pair clients with wellness coaches, but after conversations with several mentors and peers, they pivoted to health screenings. In April 2023, they raised S$1.7 million in a pre-seed round led by Forge Ventures and joined by angel investors such as the founders of ShopBack, Carousell and PatSnap.

Read more: The dark side of the Blue Zone: Living longer comes with the burden of loneliness

On how different the fundraising landscape is now compared to Seedly days, Chew says, “Most investors today focus on business models that can generate money from day one. It has to be sustainable. With Seedly, it was the kind of business where we weren’t going to earn back money. So we focused on getting more users and investors were okay with that.”

Eyeing the larger US market, where there is also a stronger interest in longevity, Mito Health participated in the startup accelerator Y Combinator programme in San Francisco from July to September 2024. 

Chew shares more about starting and exiting from Seedly and his advice for early-stage entrepreneurs.

Read more: Why running a startup is like playing 3-D chess, says Reach52’s Edward Booty

What led to your decision to exit Seedly? 

Chew Tee-Ming (TM): We got acquired twice: the first time was by ShopBack three years into the business and the second time by Compare Asia Group, now known as MoneyHero Group. After the second acquisition, I went to Switzerland for a holiday with my wife and I remember thinking, “Do I want to work on Seedly forever?” The answer became clear to me. As long as our team was being taken care of and the company mission lived on, I was okay to leave.

I also realised after working on Seedly for seven years that the mission was meaningful, but it was going to be a Singapore-only business. While I didn’t know what I was going to do next, I knew if I stayed on, I would get too comfortable. So it was largely because of personal aspirations.

How did you and Kenneth first meet?

TM: We met when I was in Silicon Valley for the National University of Singapore (NUS) Overseas Colleges programme. A university senior was asking around if anyone could host this guy coming to visit and I offered to house him in my spare room. We bonded and talked about startups a lot, and he told me how he was closing down the wire-charging business he was running at the time. 

How did that lead to starting Seedly?

TM: When we returned to Singapore, we applied for an NUS grant, which gave us S$10,000 to develop an expense tracker. We later got S$80,000 in investments from East Ventures, after a 15-minute meeting with its founding partner Willson Cuaca. We were shocked that he would invest in us because we were students, but that locked us in. 

How should early-stage founders approach the fundraising process?

TM: The pre-product phase will be challenging if you don’t have any previous record of starting a company. In this phase, ensure your team is solid and that you are the right people to address the problem you’re looking to solve.

Post-product, if you have traction, it’s easier to convince the necessary investors. If you don’t have good traction, you need to be able to convince investors how you plan to correct your strategy and what you’ve learned from the current strategy.  

For us, we don’t just want investors with a lot of money and nothing else to offer. Before we launched Mito Health, we looked for investors with connections. Since launching, we’ve been focusing on expansion, so we want investors with overseas experience who can help bring us into our next market.

Topics